Stock Overview
Revolution Medicines Inc (RVMD)
NASDAQ · Healthcare · Biotechnology
Revolution Medicines Inc is a Healthcare company with a market capitalization of $38.71B.
Market Cap
$38.71B
Price/Sales
9,035.1
Price/Book
25.8
EV/EBITDA
-9.7
Beta
1.41
EPS (TTM)
$-7.10
Profit Margin
0.0%
ROE
-76.7%
52W High
$184.39
52W Low
$34.00
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Revenue
$0.00
Gross Profit
-$16.56M
Operating Income
-$1.18B
Net Income
-$1.13B
Free Cash Flow
-$913.73M
Total Debt
$16.47M
Cash & Equivalents
$383.75M
Shareholder Equity
$1.63B
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 6, 2026 | $-2.29 | $-1.84 | -24.5% |
| Q4 2025 | February 25, 2026 | $-1.86 | $-1.58 | -17.7% |
| Q3 2025 | November 5, 2025 | $-1.61 | $-1.41 | -14.2% |
| Q2 2025 | August 6, 2025 | $-1.31 | $-1.12 | -17.0% |
| Q1 2025 | May 7, 2025 | $-1.13 | $-1.06 | -6.6% |
| Q4 2024 | February 26, 2025 | $-1.12 | $-0.96 | -16.1% |
Other Biotechnology Stocks
Frequently Asked Questions
What is Revolution Medicines Inc's market cap?
As of June 29, 2026, Revolution Medicines Inc (RVMD) has a market capitalization of $38.71B.
Does Revolution Medicines Inc pay a dividend?
Revolution Medicines Inc does not currently pay a dividend.
What sector is RVMD in?
Revolution Medicines Inc is in the Healthcare sector, specifically the Biotechnology industry.
What was Revolution Medicines Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Revolution Medicines Inc reported revenue of $0.00 and net income of -$1.13B.
Ask your own questions about RVMD
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.